Biogen to cease production of controversial Alzheimer's drug – POLITICO

Business News

1. Biogen to cease production of controversial Alzheimer’s drug  POLITICO
2. Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm  The New York Times
3. Biogen drops controversial Alzheimer’s drug Aduhelm to focus on Leqembi, experimental treatments  CNBC
4. Biogen scraps controversial Alzheimer’s drug Aduhelm  CBS News
5. Years after a polarizing approval, Biogen walks away from Aduhelm  STAT

Source: Business News